Moroğlu Arseven | Turkey | 18 Mar 2024
The Constitutional Court ruled that Article 326, Paragraph 2 of the Code of Civil Procedure (“CCP“) numbered 6100 is unconstitutional since holding…
Moroğlu Arseven | Turkey | 18 Mar 2024
The Ministry of Trade (“Ministry“) amended the Communiqué on Import Inspection of Conformity to Standards (Product Safety and Inspection: 2024/1) and…
Moroğlu Arseven | Turkey | 18 Mar 2024
In the decision of the 9th Civil Chamber of the Court of Cassation (the “Court of Cassation”) dated 20 November 2023 and numbered 2023/17941 M…
Gün + Partners | Turkey | 17 Mar 2024
1262 sayılı İspençiyari ve Tıbbi Müstahzarlar Kanunu (“1262 sayılı Kanun”) Ile 3359 sayılı Sağlık Hizmetleri Temel Kanunu’nundaki (“3359 sayılı…
Gün + Partners | Turkey | 17 Mar 2024
Named Patient Program (“NPP”) is one of the exceptional pharmaceutical importation regimes for products that are not authorized or authorized but…
Gün + Partners | Turkey | 17 Mar 2024
On 1 March 2024, the Omnibus Law Amending Certain Laws and Decree Law No. 663 (the “Omnibus Law”), which amends certain provisions of the Law No…
In-Depth
PRO
In-Depth: Public Competition Enforcement (formerly The Public Competition Enforcement Review) is an annual survey of the most important and relevant developments in public competition law enforcement in the most significant jurisdictions worldwide. Among other things, it examines the practical implications of recent enforcement activity regarding cartels, restrictive agreements, abuse of dominance, state aid and merger control.
Deriş Patents and Trademarks Agency | Turkey | 15 Mar 2024
Second (and further) medical use refers to the discovery or development of a new therapeutic use for an existing substance or composition. Throughout…